Market revenue in 2023 | USD 460.2 million |
Market revenue in 2030 | USD 926.2 million |
Growth rate | 10.5% (CAGR from 2023 to 2030) |
Largest segment | Anti-vegf agents |
Fastest growing segment | Anti-VEGF agents |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti-Allergy, Anti-VEGF agents, Anti-inflammatory, Anti-glaucoma |
Key market players worldwide | Pfizer Inc, Alcon Inc, Novartis AG ADR, Bausch Health Companies Inc, Merck & Co Inc, Regeneron Pharmaceuticals Inc, AbbVie Inc, Bayer AG, Genentech, Nicox SA Share from reverse split, Coherus BioSciences Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ophthalmic drugs market will help companies and investors design strategic landscapes.
Anti-vegf agents was the largest segment with a revenue share of 32.81% in 2023. Horizon Databook has segmented the Vietnam ophthalmic drugs market based on anti-allergy, anti-vegf agents, anti-inflammatory, anti-glaucoma covering the revenue growth of each sub-segment from 2018 to 2030.
The high patient burden is likely to boost demand for effective therapeutics to treat retinal disease in the country. There is a wide distribution network, coupled with the geographic expansion of key players in the market, which is further propelling the market growth.
However, one of the major factors hampering the growth of the market is that patients in the country generally tend to visit hospitals and seek medical help when they are completely blind, which propels the need to spread awareness and enhance healthcare facilities in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Vietnam ophthalmic drugs market , including forecasts for subscribers. This country databook contains high-level insights into Vietnam ophthalmic drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account